| Entry |
|
|---|
| Name |
Laromustine (USAN) |
|---|
| Formula |
C6H14ClN3O5S2
|
|---|
| Exact mass |
307.0063
|
|---|
| Mol weight |
307.78
|
|---|
| Structure |
|
|---|
| Class |
Antineoplastic
DG01677 Alkylating agent
|
|---|
| Efficacy |
Antineoplastic, Alkylating agent |
|---|
| Comment |
Treatment of acute myeloid leukemia
|
|---|
| Target |
DNA |
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antineoplastic
DG01677 Alkylating agent
D08939 Laromustine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 17
1 N1c N 17.9732 -16.7495
2 N1c N 19.1783 -16.0297
3 C1b C 16.7473 -16.0657
4 S4a S 17.9939 -18.1530
5 C5a C 20.4042 -16.7135
6 S4a S 19.1576 -14.6262
7 C1a C 19.2068 -13.2227
8 O3c O 20.5722 -14.6051
9 O3c O 17.7654 -14.6469
10 C1a C 18.0146 -19.5565
11 O3c O 16.5793 -18.1041
12 O3c O 19.3861 -18.1323
13 C1b C 15.5423 -16.7854
14 X Cl 14.3333 -16.1112
15 N1b N 21.6092 -15.9939
16 O5a O 20.3545 -18.0975
17 C1a C 22.8182 -16.6680
BOND 16
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 6 7 1
7 6 8 2
8 6 9 2
9 4 10 1
10 4 11 2
11 4 12 2
12 3 13 1
13 13 14 1
14 5 15 1
15 5 16 2
16 15 17 1
|
|---|
